Evidence map›Paper›PMID 40499907›Full record

ArticleAccounts of chemical research2025

Fluorinated Radicals in Divergent Synthesis via Photoredox Catalysis.

Rahul Giri, Anthony J Fernandes, Dmitry Katayev

Abstract read
In one paragraph

Article in Accounts of chemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. RapidThe Journal of organic chemistry · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Bimolecular Homolytic Substitution (SACS central science · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rahul GiriDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
Anthony J FernandesDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
Dmitry KatayevDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.ORCID 0000-0003-0131-1188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ConspectusFluorine is an essential element in pharmaceuticals, agrochemicals, and material sciences, significantly enhancing the bioactivity, metabolic stability, and physicochemical properties of organic molecules. In medicinal chemistry, nearly 20% of marketed drugs contain at least one fluorine atom within their core structure. Despite its widespread importance, naturally occurring organofluorine compounds are exceedingly rare, necessitating the development of productive synthetic strategies for fluorine incorporation. The majority of fluorination protocols at the industrial level rely on reagents made from highly reactive and hazardous hydrogen fluoride (HF) or elemental fluorine (F

Identifiers

PMID40499907
PMCPMC12224337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.